logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Ilia A Zavialov

This inventor holds 14 USPTO granted patents and 2 published patent applications and 2 EPO patents, primarily in Organic Synthesis. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., University of Southern California. Active years: 2001-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ilia A Zavialov. Retrieved from https://idiyas.com/inventor/ilia-a-zavialov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 35.7

 

Average Co-Inventor Count = 5.9

ph-index = 5

Forward Citations = 139(Granted Patents)


Location History:

  • S. Pasadena, CA (US) (2001)
  • East Windwor, NJ (US) (2007)
  • East Windsor, NJ (US) (2005 - 2008)
  • Princeton, NJ (US) (2008 - 2012)
  • Furlong, PA (US) (2017)

Company Filing History:

goldMedal10 out of 1,829 
 
Schering Corporation
 patents
silverMedal2 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal2 out of 1,695 
 
University of Southern California
 patents

Years Active: 2001-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Tetracyclic Heterocycles
Xanthine Inhibitors
CCR5 Antagonists
Amino Sugars
Diastereoselective Synthesis
Amino Polyols
D1 Receptor Antagonists
Organoboron Derivatives
Himbacine Analogs
Phosphodiesterase V
Synthesis Processes
Chemical Compounds
14 patents (USPTO):Explore Patents
1. 9725464 - Process for preparing tetracyclic heterocycle compounds (2017-08-08),
2. 8329905 - Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate (2012-12-11),
3. 8258319 - Exo- and diastereo- selective synthesis of himbacine analogs (2012-09-04),
4. 7989653 - Exo- and diastereo-selective syntheses of himbacine analogs (2011-08-02),
5. 7786301 - Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof (2010-08-31),
6. 7728135 - Synthesis of CCR5 receptor antagonists (2010-06-01),
7. 7687631 - Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate (2010-03-30),
8. 7605275 - Exo- and diastereo- selective syntheses of himbacine analogs (2009-10-20),
9. 7462746 - Amino polyols and amino sugars (2008-12-09),
10. 7326795 - Process and intermediates for the preparation of (1R,2S,5S)-3-azabicyclo[3,1,0]hexane-2-carboxamide, N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[1,1-dimethylethyl]amino]carbonylamino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl (2008-02-05),
11. 7192962 - Xanthine phosphodiesterase V inhibitor polymorphs (2007-03-20),
12. 7074923 - Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof (2006-07-11),
13. 6875866 - Process for synthesis of D1 receptor antagonists (2005-04-05),
14. 6232467 - Method for the synthesis of amines and amino acids with organoboron derivatives (2001-05-15),

Title: Inventor Ilia A Zavialov

Introduction: Ilia A Zavialov is a renowned inventor based in Princeton, NJ, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Ilia A Zavialov holds several patents in the areas of renewable energy technologies, advanced materials, and medical devices, showcasing his diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, Zavialov has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on industries worldwide.

Collaborations: Throughout his career, Ilia A Zavialov has collaborated with top scientists, engineers, and experts in multidisciplinary projects, fostering a culture of innovation and excellence in all his endeavors.

Conclusion: Ilia A Zavialov's passion for pushing the boundaries of technology and his relentless pursuit of excellence make him a standout figure in the world of inventors, with a legacy that continues to inspire future generations of innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…